Wellthy Therapeutics: Financial Breakdown
Decoding financial health metrics of Wellthy Therapeutics
- Total Revenue₹4.1 Cr9%
Prev. FY
- Total Expenses₹17.4 Cr-11%
Prev. FY
- Profit After Tax₹-13.2 Cr14%
Prev. FY
- Total Assets₹15.8 Cr-43%
Prev. FY
- Net Profit Margin-3.2%21%
Prev. FY
FAQs on Financials of Wellthy Therapeutics
No. In FY22, Wellthy Therapeutics reported a net loss of ₹13.2 Cr, so it was not profitable.
Wellthy Therapeutics's revenue grew 9.2% year-on-year, from ₹3.8 Cr in FY21 to ₹4.1 Cr in FY22.
In FY22, Wellthy Therapeutics posted revenue of ₹4.1 Cr (up 9.2% YoY) and a net loss of ₹13.2 Cr. Explore the full financials of Wellthy Therapeutics here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links

